Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Irish Stock Exchange  >  Mainstay Medical International PLC    MSTY   IE00BJYS1G50

MAINSTAY MEDICAL INTERNATIONAL PLC (MSTY)
Mes dernières consult.
Most popular
  Report  
 SummaryChartsNewsCalendarCompanyFinancialsConsensusRevisions 
OFFRE ETE Zonebourse : Jusqu'à 6 mois offerts sur tous les portefeuilles
Quotes 5-day view   End-of-day quote. End-of-day quote Irish Stock Exchange
06/12/2018 06/13/2018 06/14/2018 06/15/2018 06/18/2018 Date
15.2 15.2 15.2 15.2 15.2 Last
0 0 0 0 0 Volume
0.00% 0.00% 0.00% 0.00% 0.00% Change
Financials (EUR)
Sales 2018 7,50 M
EBIT 2018 -14,5 M
Net income 2018 -
Debt 2018 -
Yield 2018 -
Sales 2019 16,3 M
EBIT 2019 -5,30 M
Net income 2019 -
Debt 2019 -
Yield 2019 -
P/E ratio 2018 -
P/E ratio 2019
Capi. / Sales2018 17,7x
Capi. / Sales2019 8,15x
Capitalization 133 M
More Financials
Company
Mainstay Medical International Plc is a medical device company, which is engaged in the development of neurostimulation therapies.The company's focus is on the development of ReActiv8, a medical device designed to treat people with chronic low back pain.The company was founded on February 17, 2014... 
More about the company
Latest news on MAINSTAY MEDICAL INTERNATI
03/28MAINSTAY MEDICAL INTERNATIONAL PLC : Crossing thresholds
CO
02/17MAINSTAY MEDICAL INTERNATIONAL : Medical firm Mainstay gets 30m funding
AQ
02/16MAINSTAY MEDICAL INTERNATIONAL : raises 30m from new share placing
AQ
2017MAINSTAY MEDICAL INTERNATIONAL : Announces Positive Outcome of Interim Analysis
PU
2017MAINSTAY : Medical’s ReActiv8-B Clinical Trial Passes Mid-point
BU
2017MAINSTAY MEDICAL INTERNATIONAL : to Host Key Opinion Leader Event on the Chronic..
PU
2017MAINSTAY MEDICAL INTERNATIONAL : to Present at the 3rd annual Biotech and Money ..
PU
2016MAINSTAY MEDICAL INTERNATIONAL : ReActiv8-A Clinical Trial – Sustained Per..
PU
2016MAINSTAY MEDICAL INTERNATIONAL : 2016 H1 Results Notice
PU
2016WEBCAST – TUESDAY, 21 JUNE 201 : 30 pm EDT
PU
More news
Sector news : Bio Medical Devices
06/13Sanofi says on track to regain solid position in cancer drugs
RE
06/12GSK says vaccine business president to leave by year-end
RE
06/06Drugmaker Lundbeck to settle U.S. charity probe for $52.6 million
RE
06/01Lilly, Incyte Get FDA OK for Lower-Dose Rheumatoid Arthritis Drug
DJ
05/30Gap in regulating biotech drug copies prompts WHO to step in
RE
More sector news : Bio Medical Devices
Chart MAINSTAY MEDICAL INTERNATI
Duration : Period :
Mainstay Medical Internati Technical Analysis Chart | MSTY | IE00BJYS1G50 | 4-Traders
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 1
Average target price 28,0 €
Spread / Average Target 84%
Managers
NameTitle
Jason M. Hannon Chief Executive Officer & Executive Director
Oern Reidar Stuge Independent Non-Executive Chairman
Prashant Rawat Chief Operating Officer
Hugh Kavanagh Chief Financial Officer
Diane Burnside Vice President-Clinical Affairs
Sector and Competitors
1st jan.Capitalization (M$)
MAINSTAY MEDICAL INTERNATIONAL PLC18.75%154
GILEAD SCIENCES-1.97%91 317
VERTEX PHARMACEUTICALS3.44%39 504
CELLTRION, INC.--.--%33 987
REGENERON PHARMACEUTICALS-16.13%33 406
IQVIA HOLDINGS INC5.50%21 394